NCT01312987

Brief Summary

The purpose of this research study is to assess what impact an integrated educational and feeding intervention delivered to infants and children has on growth (weight and height), development (cognitive and gross motor), nutrition (dietary behaviors, food insecurity, and micronutrient status - folate, iron, zinc, vitamin A, vitamin D), and morbidity (respiratory and diarrheal) outcomes. A randomized community trial was used to implement a nutrition intervention program consisting of monthly education sessions, a lipid-based nutrition supplement, and food vouchers for local staples.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2009

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2009

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2010

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

March 5, 2011

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 11, 2011

Completed
Last Updated

August 2, 2011

Status Verified

July 1, 2011

Enrollment Period

1.1 years

First QC Date

March 5, 2011

Last Update Submit

July 31, 2011

Conditions

Outcome Measures

Primary Outcomes (5)

  • Change from baseline in height at 12 months

    Participating children were measured by trained staff every month during the 12 month intervention.

    Baseline to month 12

  • Change from baseline in hemoglobin status at 12 months

    Hemoglobin status was measured from blood samples taken by finger pricks at baseline, month 6, and month 12 of the intervention.

    Baseline to month 12

  • Change from baseline in serum transferrin status at 12 months

    Serum transferritin was measured from blood samples taken by finger pricks at baseline, month 6, and month 12 of the intervention.

    Baseline to month 12

  • Change from baseline in C-Reactive Protein levels at 12 months

    C-Reactive Protein was measured from dried blood spots collected at baseline, month 6, and month 12 of the intervention.

    Baseline to month 12

  • Change from baseline in weight at 12 months

    Participating children were weighed by trained staff every month during the 12 month intervention.

    Baseline to month 12

Secondary Outcomes (7)

  • Change from baseline in zinc levels at 12 months

    Baseline to month 12

  • Change from baseline in food insecurity status at 12 months

    Baseline to month 12

  • Change from baseline in dietary intake based on 24-Hour Food Recall at 12 months

    Baseline to month 12

  • Change from baseline in various health outcomes at 12 months

    Baseline to month 12

  • Change from baseline in acceptability of nutrition supplement at 12 months

    Baseline to month 12

  • +2 more secondary outcomes

Study Arms (2)

Nutrition intervention

EXPERIMENTAL

Receives a month's supply of the nutrition supplement, Plumpy'doz®, in addition to food voucher for each month. Participants were also allowed to attend monthly educational sessions.

Dietary Supplement: Lipid-based nutritional supplement

Control

NO INTERVENTION

Receives food vouchers each month.

Dietary Supplement: Lipid-based nutritional supplement

Interventions

After gradual introduction of the lipid-based nutritional supplement, daily dose per child is as follows: 3 teaspoons 3 x day for children younger than 12 months 4.5 teaspoons 3 x day for children older than 12 months

Also known as: Plumpy'doz®
ControlNutrition intervention

Eligibility Criteria

Age5 Months - 18 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may not qualify if:

  • Mothers have understood and signed consent forms to enable their children to participate in the study. They were willing to have their child participate in one or more blood draws, bi-monthly sessions: 1) nutrition classes and food voucher and lipid-based nutritional supplement and 2) height/weight monitoring, dietary intake questionnaire, and health outcome information. As well as the additional data assessments necessary to be considered active participants in the study.
  • Children with congenital anomalies, mental retardation, severe physical handicap, under-nutrition caused by medical conditions that contribute to under-nutrition such as heart disease, kidney failure, face and throat problems that interfere with swallowing, medical problems interfering with the absorption of food, chronic diseases such as tuberculosis, etc.
  • Children with a known allergy to peanuts and eggs will also be excluded from the study, 30% of children with known allergies to nuts also have an allergy to eggs.
  • Plans to move or change their place of residence outside of the study region in the next 2 months would make them ineligible.
  • Mothers who are younger than 16 years of age will be excluded from the study. Women younger than 16 might not understand the consent process and the importance of following the guidelines established in the research, therefore we chose not to include this group as "eligible" participants.
  • Children who are \<= -2 standard deviations below the norm for z score for weight for age. These children are severely malnourished and need to be carefully followed under the supervision of a qualified health care provider.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Malnutrition

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Jeff Heck, MD

    Shoulder to Shoulder

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 5, 2011

First Posted

March 11, 2011

Study Start

March 1, 2009

Primary Completion

April 1, 2010

Study Completion

April 1, 2010

Last Updated

August 2, 2011

Record last verified: 2011-07